Page 4 - Medicines Stock Down News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Medicines stock down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Medicines Stock Down Today - Breaking & Trending Today

Revolution Medicines' (RVMD) "Buy" Rating Reaffirmed at HC Wainwright

HC Wainwright reissued their buy rating on shares of Revolution Medicines (NASDAQ:RVMD – Free Report) in a report issued on Wednesday morning, Benzinga reports. HC Wainwright currently has a $32.00 price objective on the stock. HC Wainwright also issued estimates for Revolution Medicines’ Q2 2023 earnings at ($0.81) EPS, Q3 2023 earnings at ($0.91) EPS, […] ....

United States , Jeff Cislini , Jack Anders , Group Plc , Ensign Peak Advisors Inc , Securities Exchange Commission , Revolution Medicines Inc , Needham Company , Ameritas Investment Partners Inc , Voya Investment Management , Jpmorgan Chase Co , Revolution Medicines , Free Report , Moderate Buy , Medicines Stock Down , Get Free Report , General Counsel Jeff Cislini , Exchange Commission , Investment Management , General Group Plc , Wisconsin Investment Board , Peak Advisors Inc , Ameritas Investment Partners , Investment Partners , Revolution Medicines Daily , Nasdaq Rvmd ,

Blueprint Medicines (NASDAQ:BPMC) Given New $83.00 Price Target at The Goldman Sachs Group

Blueprint Medicines (NASDAQ:BPMC) Given New $83.00 Price Target at The Goldman Sachs Group
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Percyh Carter , Morgan Stanley , Associates Corp , Lazard Asset Management , Blueprint Medicines Company Profile , Goldman Sachs Group , Nisa Investment Advisors , Bessemer Group Inc , Blueprint Medicines Corporation , Needham Company , Blueprint Medicines , Free Report , Moderate Buy , Medicines Stock Down , Get Free Report , Asset Management , Forest Capital Management , Investment Advisors , Medicines Corporation , Blueprint Medicines Daily ,

Blueprint Medicines Co. (NASDAQ:BPMC) Shares Acquired by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC grew its stake in Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 158.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,605 shares of the biotechnology company’s stock after buying an additional 983 shares during the quarter. […] ....

United States , Percyh Carter , Nisa Investment Advisors , Morgan Stanley , Linden Thomas Advisory Services , Tekla Capital Management , Goldman Sachs Group , Blueprint Medicines Co , Emerald Advisers , Securities Exchange Commission , Needham Company , Blueprint Medicines Corporation , Capital Partners , Blueprint Medicines , Free Report , Investment Advisors , Ivy Capital Management , Thomas Advisory Services , Medicines Stock Down , Get Free Report , Medicines Corporation , Visit Holdingschannel , Blueprint Medicines Daily , Nasdaq Bpmc , Sec Filings , Hedge Fund Holdings ,

Revolution Medicines (RVMD) to Release Earnings on Tuesday

Revolution Medicines (RVMD) to Release Earnings on Tuesday
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Hong Kong , Jeff Cislini , Stephen Michael Kelsey , Revolution Medicines Inc , Securities Exchange Commission , Tower Research Capital , Revolution Medicines Company Profile , Jpmorgan Chase Co , Needham Company , Sei Investments Co , Principal Financial Group Inc , Hong Kong Ltd , Revolution Medicines , Get Free Report , Medicines Stock Down , Exchange Commission , General Counsel Jeff Cislini , Kong Ltd , Research Capital , Eight Capital , Principal Financial Group , Financial Group , Revolution Medicines Daily ,

Short Interest in Blueprint Medicines Co. (NASDAQ:BPMC) Declines By 7.3%

Blueprint Medicines Co. (NASDAQ:BPMC – Get Free Report) was the recipient of a large drop in short interest during the month of July. As of July 15th, there was short interest totalling 3,580,000 shares, a drop of 7.3% from the June 30th total of 3,860,000 shares. Based on an average daily volume of 636,300 shares, […] ....

United States , Percyh Carter , Wells Fargo Company , Brown Advisory Inc , Capital International , Morgan Stanley , Blueprint Medicines Co , Blueprint Medicines Corporation , Blueprint Medicines , Get Free Report , Montreal Can , Strs Ohio , Medicines Stock Down , Medicines Corporation , Blueprint Medicines Daily , Nasdaq Bpmc ,